rs121913377, BRAF

N. diseases: 480
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Erdheim-Chester Disease
CUI: C0878675
Disease: Erdheim-Chester Disease
0.100 GeneticVariation BEFREE BRAF V600E mutations are not an oncogenic driver of solitary xanthogranuloma and reticulohistiocytoma: Testing may be useful in screening for Erdheim-Chester disease. 31639332 2019
Erdheim-Chester Disease
CUI: C0878675
Disease: Erdheim-Chester Disease
0.100 GeneticVariation BEFREE Vemurafenib as first-line therapy in <i>BRAF</i>-V600E-mutant Erdheim-Chester disease with CNS involvement. 31748352 2019
Erdheim-Chester Disease
CUI: C0878675
Disease: Erdheim-Chester Disease
0.100 GeneticVariation BEFREE Significant differences were the eyelid involvement in XG, orbital nerve involvement, and an elevated IgG4+/IgG+ ratio in IgG4-RD and the only genetic abnormality found was BRAF V600E mutation in the Erdheim-Chester disease subgroup of XG. 26882062 2017
Erdheim-Chester Disease
CUI: C0878675
Disease: Erdheim-Chester Disease
0.100 GeneticVariation BEFREE We collected CSF from patients with BRAF V600E or K-mutated melanoma (N=8) or BRAF V600E mutated Erdheim-Chester Disease (ECD) (N=3) with suspected central nervous system (CNS) involvement on the basis of neurological symptoms (10/11), MRI imaging (8/11), or both. 27863426 2016
Erdheim-Chester Disease
CUI: C0878675
Disease: Erdheim-Chester Disease
0.100 GeneticVariation BEFREE Evaluation of clinicopathologic characteristics and the BRAF V600E mutation in Erdheim-Chester disease among Chinese adults. 26858028 2016
Erdheim-Chester Disease
CUI: C0878675
Disease: Erdheim-Chester Disease
0.100 GeneticVariation BEFREE A BRAF(V600E) mutation in a non-LCH histiocytic lesion with a xanthogranuloma phenotype (CD163/CD68/CD14/fascin/Factor 13a) should prompt an Erdheim-Chester disease workup. 26454140 2016
Erdheim-Chester Disease
CUI: C0878675
Disease: Erdheim-Chester Disease
0.100 GeneticVariation BEFREE Patients with Langerhans cell histiocytosis (LCH) and Erdheim-Chester disease (ECD) have a high frequency of BRAF(V600E) mutations and respond to RAF inhibitors. 25324352 2015
Erdheim-Chester Disease
CUI: C0878675
Disease: Erdheim-Chester Disease
0.100 GeneticVariation BEFREE Erdheim-Chester disease (ECD) is a rare form of non-Langerhans-cell histiocytosis, associated in more than 50% of cases to BRAF(V600E) mutations in early multipotent myelomonocytic precursors or in tissue-resident histiocytes. 25744785 2015
Erdheim-Chester Disease
CUI: C0878675
Disease: Erdheim-Chester Disease
0.100 GeneticVariation BEFREE Does the BRAF(V600E) mutation herald a new treatment era for Erdheim-Chester disease? A case-based review of a rare and difficult to diagnose disorder. 25735579 2015
Erdheim-Chester Disease
CUI: C0878675
Disease: Erdheim-Chester Disease
0.100 GeneticVariation BEFREE Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease. 25422482 2015
Erdheim-Chester Disease
CUI: C0878675
Disease: Erdheim-Chester Disease
0.100 GeneticVariation BEFREE Erdheim-Chester disease with an 18F-fluorodeoxyglucose-avid breast mass and BRAF V600E mutation. 24531980 2014
Erdheim-Chester Disease
CUI: C0878675
Disease: Erdheim-Chester Disease
0.100 GeneticVariation BEFREE BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease. 25003820 2014
Erdheim-Chester Disease
CUI: C0878675
Disease: Erdheim-Chester Disease
0.100 GeneticVariation BEFREE High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. 22879539 2012